NAFLD-related mortality: simple hepatic steatosis is not as ‘benign’ as thought

Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis

(2020) Rod S. Taylor et al.   GASTROENTEROLOGY

NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications

(2020) Giovanni Targher et al.   GUT

Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort

(2020) Tracey G Simon et al.   GUT

The Risk of Incident Extrahepatic Cancers is higher in Nonalcoholic Fatty Liver Disease than Obesity - a Longitudinal Cohort Study

(2019) Alina M. Allen et al.   JOURNAL OF HEPATOLOGY

Attributable Fractions of NAFLD for Mortality in the United States: Results From NHANES III With 27 Years of Follow‐up

(2019) Christian S. Alvarez et al.   HEPATOLOGY

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease

(2018) Eduardo Vilar-Gomez et al.   GASTROENTEROLOGY

Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

(2017) Anna M. Diehl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Mechanisms behind the link between obesity and gastrointestinal cancers

(2014) Herbert Tilg et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis

(2011) V. W.-S. Wong et al.   GUT

Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia

(2011) A. Stadlmayr et al.   JOURNAL OF INTERNAL MEDICINE